$HSDT
HELIUS MEDICAL TECHNOLOGIES, INC.

2024 Q4 Form 10-Q Financial Statement

#000155837024015344 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $51.00K
YoY Change -64.34%
Cost Of Revenue $187.0K
YoY Change 0.0%
Gross Profit -$136.0K
YoY Change 209.09%
Gross Profit Margin -266.67%
Selling, General & Admin $2.850M
YoY Change 29.78%
% of Gross Profit
Research & Development $1.077M
YoY Change 49.17%
% of Gross Profit
Depreciation & Amortization $16.00K
YoY Change -50.0%
% of Gross Profit
Operating Expenses $3.934M
YoY Change 26.54%
Operating Profit -$4.070M
YoY Change 29.08%
Interest Expense -$1.000K
YoY Change -101.47%
% of Operating Profit
Other Income/Expense, Net $384.0K
YoY Change -175.29%
Pretax Income -$3.686M
YoY Change 0.63%
Income Tax
% Of Pretax Income
Net Earnings -$3.686M
YoY Change 0.63%
Net Earnings / Revenue -7227.45%
Basic Earnings Per Share -$0.99
Diluted Earnings Per Share -$0.99
COMMON SHARES
Basic Shares Outstanding 3.728M 3.576M
Diluted Shares Outstanding 3.741M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.468M
YoY Change -47.42%
Cash & Equivalents $3.500M
Short-Term Investments
Other Short-Term Assets $640.0K
YoY Change -28.33%
Inventory $774.0K
Prepaid Expenses $299.0K
Receivables $25.00K
Other Receivables $499.0K
Total Short-Term Assets $5.406M
YoY Change -36.96%
LONG-TERM ASSETS
Property, Plant & Equipment $156.0K
YoY Change -14.29%
Goodwill
YoY Change
Intangibles $2.000K
YoY Change -93.55%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $179.0K
YoY Change -35.61%
TOTAL ASSETS
Total Short-Term Assets $5.406M
Total Long-Term Assets $179.0K
Total Assets $5.585M
YoY Change -36.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $743.0K
YoY Change 49.5%
Accrued Expenses $711.0K
YoY Change -20.65%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.496M
YoY Change 4.25%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $290.0K
YoY Change -93.41%
Total Long-Term Liabilities $290.0K
YoY Change -93.41%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.496M
Total Long-Term Liabilities $290.0K
Total Liabilities $1.786M
YoY Change -69.38%
SHAREHOLDERS EQUITY
Retained Earnings -$167.8M
YoY Change 5.6%
Common Stock $172.0M
YoY Change 5.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.799M
YoY Change
Total Liabilities & Shareholders Equity $5.585M
YoY Change -36.92%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$3.686M
YoY Change 0.63%
Depreciation, Depletion And Amortization $16.00K
YoY Change -50.0%
Cash From Operating Activities -$2.771M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -149.0K
YoY Change
NET CHANGE
Cash From Operating Activities -2.771M
Cash From Investing Activities 0.000
Cash From Financing Activities -149.0K
Net Change In Cash -2.920M
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$2.771M
Capital Expenditures $0.00
Free Cash Flow -$2.771M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2024#ProductMember
CY2023Q3 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2024#ProductMember
us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2024#ProductMember
CY2024Q3 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2024#ProductMember
us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2024#ProductMember
CY2023Q3 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2024#ProductMember
us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2024#ProductMember
CY2024Q3 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2024#ProductMember
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
dei Entity Central Index Key
EntityCentralIndexKey
0001610853
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2024Q3 hsdt Number Of Operating Leases
NumberOfOperatingLeases
1
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
false
CY2023Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.02
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38445
dei Entity Registrant Name
EntityRegistrantName
HELIUS MEDICAL TECHNOLOGIES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
36-4787690
dei Entity Address Address Line1
EntityAddressAddressLine1
642 Newtown Yardley Road, Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Newtown
dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
18940
dei City Area Code
CityAreaCode
215
dei Local Phone Number
LocalPhoneNumber
944-6100
dei Security12b Title
Security12bTitle
Class A Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
HSDT
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3728172
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3468000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5182000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
25000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
117000
CY2024Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
499000
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
520000
CY2024Q3 us-gaap Inventory Net
InventoryNet
774000
CY2023Q4 us-gaap Inventory Net
InventoryNet
457000
CY2024Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
640000
CY2023Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
1162000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
5406000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
7438000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
156000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
178000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
24000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
52000
CY2024Q3 us-gaap Assets
Assets
5585000
CY2023Q4 us-gaap Assets
Assets
7692000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
743000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
531000
CY2024Q3 hsdt Accrued And Other Current Liabilities.
AccruedAndOtherCurrentLiabilities.
688000
CY2023Q4 hsdt Accrued And Other Current Liabilities.
AccruedAndOtherCurrentLiabilities.
1260000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
23000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
45000
CY2024Q3 us-gaap Deferred Credits And Other Liabilities Current
DeferredCreditsAndOtherLiabilitiesCurrent
42000
CY2023Q4 us-gaap Deferred Credits And Other Liabilities Current
DeferredCreditsAndOtherLiabilitiesCurrent
43000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1496000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1879000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12000
CY2024Q3 us-gaap Deferred Credits And Other Liabilities Noncurrent
DeferredCreditsAndOtherLiabilitiesNoncurrent
94000
CY2023Q4 us-gaap Deferred Credits And Other Liabilities Noncurrent
DeferredCreditsAndOtherLiabilitiesNoncurrent
128000
CY2024Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
196000
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3323000
CY2024Q3 us-gaap Liabilities
Liabilities
1786000
CY2023Q4 us-gaap Liabilities
Liabilities
5342000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3646121
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3646121
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
714590
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
714590
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
4000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
171993000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
162979000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-167771000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-159957000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-427000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-673000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
3799000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2350000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5585000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7692000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
40000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
132000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
335000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
482000
CY2024Q3 us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
11000
CY2023Q3 us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
11000
us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
33000
us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
28000
CY2024Q3 us-gaap Revenues
Revenues
51000
CY2023Q3 us-gaap Revenues
Revenues
143000
us-gaap Revenues
Revenues
368000
us-gaap Revenues
Revenues
510000
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
187000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
187000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
428000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
493000
CY2024Q3 us-gaap Gross Profit
GrossProfit
-136000
CY2023Q3 us-gaap Gross Profit
GrossProfit
-44000
us-gaap Gross Profit
GrossProfit
-60000
us-gaap Gross Profit
GrossProfit
17000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2850000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2196000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7940000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7639000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1077000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
722000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2735000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2292000
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
32000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
21000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
109000
CY2023Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
159000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
159000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
3934000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
3109000
us-gaap Operating Expenses
OperatingExpenses
10696000
us-gaap Operating Expenses
OperatingExpenses
10199000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4070000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3153000
us-gaap Operating Income Loss
OperatingIncomeLoss
-10756000
us-gaap Operating Income Loss
OperatingIncomeLoss
-10182000
CY2024Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1000
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
68000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-14000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
257000
CY2024Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
152000
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-393000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
3027000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2051000
CY2024Q3 hsdt Foreign Currency Transaction Including Other Gain Loss Before Tax
ForeignCurrencyTransactionIncludingOtherGainLossBeforeTax
178000
CY2023Q3 hsdt Foreign Currency Transaction Including Other Gain Loss Before Tax
ForeignCurrencyTransactionIncludingOtherGainLossBeforeTax
-192000
hsdt Foreign Currency Transaction Including Other Gain Loss Before Tax
ForeignCurrencyTransactionIncludingOtherGainLossBeforeTax
-251000
hsdt Foreign Currency Transaction Including Other Gain Loss Before Tax
ForeignCurrencyTransactionIncludingOtherGainLossBeforeTax
62000
CY2024Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
55000
CY2023Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
7000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
180000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
7000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
384000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-510000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2942000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2377000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3686000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3663000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7814000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7805000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-3686000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3663000
us-gaap Net Income Loss
NetIncomeLoss
-7814000
us-gaap Net Income Loss
NetIncomeLoss
-7805000
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-182000
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
191000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
246000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-71000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3868000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3472000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7568000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7876000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.99
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.49
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-13.60
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.99
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-13.60
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3740625
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
667809
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2363718
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
573950
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3740625
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
667809
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2363718
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
573950
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
6339000
CY2024Q3 hsdt Stock Issued During Period Value Warrant Exercised
StockIssuedDuringPeriodValueWarrantExercised
1000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1327000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-182000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-3686000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
3799000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
4572000
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
284000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
36000
CY2023Q3 hsdt Stock Issued During Period Value Warrant Exercised
StockIssuedDuringPeriodValueWarrantExercised
1270000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
403000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
191000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3663000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3021000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2350000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2961000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
4829000
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1132000
hsdt Stock Issued During Period Value Warrant Exercised
StockIssuedDuringPeriodValueWarrantExercised
265000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2094000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
246000
us-gaap Net Income Loss
NetIncomeLoss
-7814000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
3799000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
8151000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
284000
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
36000
hsdt Stock Issued During Period Value Warrant Exercised
StockIssuedDuringPeriodValueWarrantExercised
1270000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1228000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-71000
us-gaap Net Income Loss
NetIncomeLoss
-7805000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3021000
us-gaap Profit Loss
ProfitLoss
-7814000
us-gaap Profit Loss
ProfitLoss
-7805000
hsdt Derivative Gain Loss On Derivative Net Cash Flow Impact
DerivativeGainLossOnDerivativeNetCashFlowImpact
3026000
hsdt Derivative Gain Loss On Derivative Net Cash Flow Impact
DerivativeGainLossOnDerivativeNetCashFlowImpact
2051000
us-gaap Share Based Compensation
ShareBasedCompensation
2094000
us-gaap Share Based Compensation
ShareBasedCompensation
1228000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-244000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
71000
us-gaap Depreciation
Depreciation
27000
us-gaap Depreciation
Depreciation
32000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
21000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
109000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
159000
us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
28000
us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
2000
us-gaap Operating Lease Expense
OperatingLeaseExpense
31000
us-gaap Operating Lease Expense
OperatingLeaseExpense
38000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-89000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
23000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-20000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-236000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
345000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-66000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-390000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-323000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-34000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-40000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
214000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-130000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-571000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-431000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-31000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-24000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8663000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8382000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-26000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2961000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
284000
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
4829000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
164000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
207000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1000000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
36000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6954000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
455000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1714000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7953000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5182000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14549000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3468000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6596000
hsdt Derivative Warrant Liability Reclassified To Equity On Exercise Of Warrants
DerivativeWarrantLiabilityReclassifiedToEquityOnExerciseOfWarrants
101000
hsdt Derivative Warrant Liability Reclassified To Equity On Exercise Of Warrants
DerivativeWarrantLiabilityReclassifiedToEquityOnExerciseOfWarrants
628000
hsdt Deferred Offering Costs Reclassified To Equity Upon Public Offering
DeferredOfferingCostsReclassifiedToEquityUponPublicOffering
132000
hsdt Warrant Proceeds Due From Transfer Agent
WarrantProceedsDueFromTransferAgent
435000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3500000
us-gaap Operating Income Loss
OperatingIncomeLoss
-10800000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-167800000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
300000
CY2024Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
349000
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
351000
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
375000
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
67000
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
137000
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
96000
CY2024Q3 us-gaap Inventory Gross
InventoryGross
861000
CY2023Q4 us-gaap Inventory Gross
InventoryGross
514000
CY2024Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
87000
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
57000
CY2024Q3 us-gaap Inventory Net
InventoryNet
774000
CY2023Q4 us-gaap Inventory Net
InventoryNet
457000
us-gaap Inventory Write Down
InventoryWriteDown
2000
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
299000
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
689000
CY2024Q3 hsdt Inventory Related Assets Current
InventoryRelatedAssetsCurrent
334000
CY2023Q4 hsdt Inventory Related Assets Current
InventoryRelatedAssetsCurrent
333000
CY2024Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
7000
CY2023Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
140000
CY2024Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
640000
CY2023Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
1162000
CY2023Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
446000
CY2024Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
586000
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
509000
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
36000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
52000
CY2024Q3 hsdt Accrued Franchise Fee Current
AccruedFranchiseFeeCurrent
30000
CY2023Q4 hsdt Accrued Franchise Fee Current
AccruedFranchiseFeeCurrent
168000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
36000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
85000
CY2024Q3 hsdt Accrued And Other Current Liabilities.
AccruedAndOtherCurrentLiabilities.
688000
CY2023Q4 hsdt Accrued And Other Current Liabilities.
AccruedAndOtherCurrentLiabilities.
1260000
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
11000
us-gaap Operating Lease Cost
OperatingLeaseCost
31000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
14000
us-gaap Operating Lease Cost
OperatingLeaseCost
41000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
12000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
12000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
24000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
23000
hsdt Derivative Warrant Liability Reclassified To Equity On Exercise Of Warrants
DerivativeWarrantLiabilityReclassifiedToEquityOnExerciseOfWarrants
101000
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1327000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
403000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2094000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1228000
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1900000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P0Y9M18D
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3686000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3663000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7814000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7805000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3740625
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
667809
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2363718
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
573950
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.99
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.49
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-13.60
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-3686000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-3663000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-7814000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-7805000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3740625
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
667809
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2363718
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
573950
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.99
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-13.60
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
40000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
132000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
335000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
482000
CY2024Q3 us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
11000
CY2023Q3 us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
11000
us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
33000
us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
28000
CY2024Q3 us-gaap Revenues
Revenues
51000
CY2023Q3 us-gaap Revenues
Revenues
143000
us-gaap Revenues
Revenues
368000
us-gaap Revenues
Revenues
510000
CY2023Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
159000
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001558370-24-015344-index-headers.html Edgar Link pending
0001558370-24-015344-index.html Edgar Link pending
0001558370-24-015344.txt Edgar Link pending
0001558370-24-015344-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hsdt-20240930.xsd Edgar Link pending
hsdt-20240930x10q.htm Edgar Link pending
hsdt-20240930xex31d1.htm Edgar Link pending
hsdt-20240930xex31d2.htm Edgar Link pending
hsdt-20240930xex32d1.htm Edgar Link pending
hsdt-20240930xex32d2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
hsdt-20240930_cal.xml Edgar Link unprocessable
hsdt-20240930x10q_htm.xml Edgar Link completed
hsdt-20240930_def.xml Edgar Link unprocessable
hsdt-20240930_lab.xml Edgar Link unprocessable
hsdt-20240930_pre.xml Edgar Link unprocessable
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending